Deals this week: Catalyst Biosciences, Poxel SA, BioXcel Therapeutics
Catalyst Biosciences Inc has issued two million shares priced at $34 a share through an underwritten public offering to raise…
Catalyst Biosciences Inc has issued two million shares priced at $34 a share through an underwritten public offering to raise…